Transdermal patches (adhesive patches placed on the skin) may also be used to deliver a steady dose through the skin and into the bloodstream. Testosterone-containing creams and gels that are applied daily to the skin are also available, but absorption is inefficient (roughly 10%, varying between individuals) and these treatments tend to be more expensive. Individuals who are especially physically active and/or bathe often may not be good candidates, since the medication can be washed off and may take up to six hours to be fully absorbed. There is also the risk that an intimate partner or child may come in contact with the application site and inadvertently dose himself or herself; children and women are highly sensitive to testosterone and can suffer unintended masculinization and health effects, even from small doses. Injection is the most common method used by individuals administering AAS for non-medical purposes. 
My foot & ankle specialist prescribed a compounded transdermal cream for nerve pain along the outside of my foot right below the ankle from toes to heels & it helps. I’m also been using it for fibromyalgia pain. I recently tried it for varicose vein pain & have found it works for that too. Very pleased with results. I am diabetic so it also greatly helps with diabetic nerve pain in the feet. Very easy to use, mine comes in a clear plastic container that dispenses the right amount for each dose much like a lotion pump. Just need to rub it in well. No mess, no pill. I think a physician has to place the order with the pharmacy.
Clinical photograph and radiograph demonstrate Haglund's deformity and calcifications consistent with insertional Achilles tendonopathy. Failure of conservative management and loss of function are indications for surgical management. Given the large Haglund's deformity on radiograph, calcaneal exostectomy is preferable to tendon debridement alone.
Hartog et al reviewed a series of 29 cases of chronic Achilles tendinosis treated surgically including supplementation with FHL transfer. Good to excellent clinical results were reported with no major complications.
McGarvey reviewed the clinical results of 22 insertional Achilles tendonopathy treated surgically finding a clinical satisfaction rate of 82%. Hartog reports on 29 cases of FHL augmentation of chronic Achilles tendonosis finding excellent or good results in 26 of 29 and no report of functional deficit or deformity of the hallux.
Kolodziej conducted a cadaveric study to evaluate the integrity of the insertion of the Achilles tendon. The greatest margin of safety was found to be offered by a superior to inferior resection (better than medial/lateral and oblique) and that as much as 50% of the tendon could be resected without sacrificing significant strength to failure.